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A 65-year-old man with a 1-year
clinical history of recurrent flush
and diarrhoea was admitted to our
hospital for severe right-sided
heart failure. Abdominal computed
tomography scan showed carcinoid
tumour originating from gut with
hepatic metastases. Chemotherapy
with octreotid and arterial
chemo-embolization of the hepatic
metastases was initiated. Transthor-
acic echocardiography revealed
severe tricuspid and pulmonary
valve regurgitation with dilation of
the right heart chambers (Figure
1A–E). Together with the history
and the thickened, retracted, and
immobile leaflets, this was sugges-
tive of carcinoid heart disease.
Velocity-encoded cardiac-magnetic
resonance imaging confirmed the
severity of pulmonary [Figure 2A–F;
regurgitant fraction (RF)¼ 45%] and tricuspid valve regurgitations (Figure 3A–F). Tricuspid regurgitant volume was calculated as the differ-
ence of the net pulmonary forward volume and the tricuspid inflow in diastole as well as direct quantification of flow at the tricuspid annulus
(illustrated here) with similar results (RF calculated at 58 and 57%, respectively). The patient underwent successful cardiac surgery with pla-
cement of bioprosthetic valves, less prone to thrombotic and haemorrhagic complications in this situation. The operative settings showed
pathological findings suggestive of carcinoid heart disease (Figure 4) with thickened and retracted leaflets (black arrow) and chordae (white
arrow) confirmed by histology revealing valvular fibrosis and no inflammatory changes. Early post-operative follow-up showed substantial
clinical improvement of right-sided heart failure.
Carcinoid heart disease is a rare cause of intrinsic tricuspid and pulmonary valve disease and leads to important morbidity and mor-
tality caused by right-sided heart failure. Medical and in appropriate cases surgical treatment can improve quality of life and in same
cases survival. This case illustrates the importance of quantification of valve regurgitations, especially in the pulmonary position, as
pre-operative strategy for optimal clinical decision-making in carcinoid heart disease.
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